Home » Healthcare » Induced Pluripotent Stem Cell (IPSC) Market

Induced Pluripotent Stem Cell (IPSC) Market By Process (Manual, Automated) By Product (Instruments/Devices, Automated Platforms, Consumables & Kits, Services) By Workflow (Reprogramming, Cell Culture, Cell Characterization/Analysis, Engineering, Others) By Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others) By End Use (Research & Academic Institutes, Biotechnology & Pharmaceutical) – Growth, Future Prospects, And Competitive Analysis, 2016 -2028

Summary
Table Of Content

About this report

The global Induced Pluripotent Stem Cell (IPSC) Market report explores the critical analysis of the Induced Pluripotent Stem Cell (IPSC) industry using key parameters. The report consists of investment strategies, the need for investments in the Induced Pluripotent Stem Cell (IPSC) industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Induced Pluripotent Stem Cell (IPSC) industry, as well as how economic and non-economic barriers are helping the Induced Pluripotent Stem Cell (IPSC) market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Induced Pluripotent Stem Cell (IPSC) Market?

In 2021, with a revenue share of 78%, the manual IPSC production process segment dominated the global market. By simply improving the manual processes that are frequently employed to reprogramme patient cells, the IPSC generation process can be made more economical and effective. The segment’s supremacy is a result of its usefulness for manufacturing several IPSC lines concurrently.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Cell culture was the predominant workflow sector in 2021, with a revenue share of more than 37%. It is anticipated that it will continue to grow at a constant CAGR during the forecast period. Cell culture is a key procedure in producing IPSC since investigations of stem cell activity and differentiation in development is challenging, expensive, and time-consuming.

Which region dominated the Induced Pluripotent Stem Cell (IPSC) Market?

In 2021, North America dominated the market, accounting for more than 52% of total sales. The market growth in the area was facilitated by robust business models in the U.S. and Canada. Additionally, businesses are funding IPSC-related research initiatives. For instance, by providing funding for IPSC research and its translation into clinical applications, the California Institute for Regenerative Medicine (CIRM) supports research institutes. Additionally, the Regenerative Medicine Program has been launched by the National Health Institute (NIH). The purpose of this program is to provide tools that will encourage the use of IPSCs for therapeutic purposes. Additionally, the RPM encourages sharing IPS cell lines for use in clinical and lab research.

What is the competitive environment of the Induced Pluripotent Stem Cell (IPSC) Market?

The IPSC industry’s competitive environment offers information on the total economic profit made by suppliers and businesses, the sales and revenues produced in this sector, the IPSC market share globally, the business organization overview, the introduction of new products, and the opportunities for the IPSC market. Key players are focused on enhancing their product portfolio through alliances and partnerships with other significant companies and expanding their products through significant R&D. For instance, in January 2021, Bristol Myers Co. awarded USD 6 million to Evotec SE for their collaboration on IPS cell-based neuroscience. This collaboration should aid in the discovery of disease-modifying therapies for a variety of neurogenerative illnesses. Axol Biosciences expanded its service offering in October 2020 by introducing Multi-Electrode Array (MEA) screening for human IPSC-derived cells.

Executive Summary

What are the Technical developments being developed in the Induced Pluripotent Stem Cell (IPSC) Market?

IPSC are cells with the ability to differentiate into any adult or germ cell under particular growing conditions. As a result, all major organs today have developed functional parenchymal cells. The creation of tissue constructs based on developmental biology and tissue engineering methodology has increased significantly in recent years, paving the way for the use of IPSCs to create tissues and glands that can be utilized to replace failing or defective parts of any important organs.

Which are the key investments by the players in the Induced Pluripotent Stem Cell (IPSC) Market?

Induced pluripotent stem cell suppliers are increasing their investments in research and development to advance their offerings in stem cell therapies which are gaining popularity for treating multiple chronic diseases. For instance, in April 2022, TreeFrog Therapeutics, a biotechnology firm focused on making affordable stem cell therapies, announced the launch of a grant worth US$ 100,000. The Stem Cell SpaceShot Grant will be open to PhD-level scientists and students to advance stem cell biology research and promote scientific discoveries. Bristol Myers Co. awarded USD 6 million to Evotec SE in January 2021 for collaboration in IPS cell-based neuroscience. This collaboration should aid in the discovery of disease-modifying therapies for a variety of neurogenerative illnesses. Axol Biosciences expanded its service offering in October 2020 by introducing Multi-Electrode Array (MEA) screening for human IPSC-derived cells.

Some of the major players in the market are Lonza; Axol Biosciences Ltd.; Evotec; Hitachi Ltd.; Merck KGaA; REPROCELL Inc.; Fate Therapeutics; Thermo Fisher Scientific, Inc.; StemCellFactory III; and Applied StemCell Inc.

What are the Major Driving Factors for the Induced Pluripotent Stem Cell (IPSC) Market?

The creation of an endless supply of any human cell required for therapeutic reasons is made possible by induced pluripotent stem cells (IPSCs), which are obtained from skin or blood cells and reprogrammed to revert to a pluripotent state similar to that of an embryo. The ability of induced pluripotent stem cells to produce any cell or tissue needed by the body to fight or treat diseases like leukemia, spinal cord injury, heart disease, and diabetes is the main factor driving the trend toward their use. Another benefit is that IPSCs can be produced using the same patient’s tissue who will receive the transplant, preventing immunological rejection. Increased research funding, an increase in the number of genomics projects, and an increase in the application of genome editing in customized medicine are further factors boosting the market’s expansion. However, the public’s misperception of genetic research is likely to impede market expansion.

What Major Risks for the Induced Pluripotent Stem Cell (IPSC) Market?

The market’s expansion may be hampered by high IPSC production costs, tumorigenicity, immunogenicity, and heterogeneity. Over time in in-vitro culture, the IPS cells may display chromosomal instability, loss of heterozygosity, copy number variation, and genetic instability. Additionally, IPSCs are often grown and generated using a feeder layer method, which can result in significant lot-to-lot variability, safety and regulatory problems, and issues with process scalability.

Which is the key Process in the Induced Pluripotent Stem Cell (IPSC) Market?

With a revenue share of 78.13% in 2021, the manual IPSC production process segment dominated the global market. By simply improving the manual processes that are frequently employed to reprogramme patient cells, the IPSC generation process can be made more economical and effective. Converting somatic cells into IPS involves several frequently used manual techniques and devices and is primarily done by hand. The manual IPSC creation technique necessitates trained workers who can identify appropriate colonies and efficiently complete various generating activities. The segment’s supremacy is a result of its usefulness for manufacturing several IPSC lines concurrently.

The fastest CAGR is anticipated in the automated IPSC production process between 2021 and 2028. The demand for automation systems is rising due to the growing need for minimally variable, large-scale, reproducible stem cells and differentiated progeny generation. To facilitate research on various disorders, such as diabetes, cardiovascular disease, and neurodegenerative diseases, several nations have launched IPSC line collection projects.

How is the Induced Pluripotent Stem Cell (IPSC) Market performing in regions?

North America dominated with more than 52% of the market’s total sales in 2021. Strong business concepts in the United States and Canada helped the local market flourish. Additionally, businesses are supporting research projects connected to IPSC. For instance, the California Institute for Regenerative Medicine (CIRM) assists research institutes by sponsoring IPSC studies and their conversion into clinical applications. Additionally, the National Health Institute has started the Regenerative Medicine Program. This program’s goal is to offer resources that promote the use of IPSCs for therapeutic purposes. The RPM also promotes the exchange of IPS cell lines for use in clinical and laboratory research.

Over the forecast period, stable growth is anticipated in Europe. Research on IPSCs in this area is advancing thanks to the creation of the EBiSC. The mission of the EBiSC is to provide research-grade, quality-controlled IPS cell lines, data, and disease-relevant cell services. Additionally, it is a non-profit IPS cell lines bank for business and academia to provide dependable, superior tools for developing cutting-edge medicines.

Companies are entering into collaborations to increase the availability of their IPSC-derived medicines, which will, in turn, fuel regional research efforts. To create human IPSC-derived medicines for the treatment of ophthalmic disorders, Hopstem Biotechnology and Neurophth Therapeutics joined forces in June 2021. Hopstem Biotechnology got an upfront payment and development milestone payments under this strategic collaboration to create a candidate cell product to treat degenerative retinal degeneration.

What is the regulatory landscape for the Induced Pluripotent Stem Cell (IPSC) Market?

Patients have a great deal of optimism about developing individualized pluripotent stem cells for research and potential therapeutics. However, before they can be employed as therapeutic reagents, such cells must overcome severe technical and regulatory difficulties. Here, we examine two potential sources of customized pluripotent stem cells: induced pluripotent stem cells (IPSCs), produced through direct reprogramming of adult somatic cells, and nuclear transfer-derived embryonic stem cells (NT-ESCs). In certain ways, the regulatory obstacles faced by stem cells obtained from fertilization-produced embryos are much higher than those faced by stem cells from both sources of individualized pluripotent stem cells.

What is the Market Size of the Induced Pluripotent Stem Cell (IPSC) regarding value?

The global Induced Pluripotent Stem Cell (IPSC) Market is anticipated to grow at a substantial CAGR of 8.4% in the upcoming years. The global Induced Pluripotent Stem Cell (IPSC) industry was estimated to be worth USD 2,194.2 million in 2021 and was expected to be worth USD 3,560.02 million by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Induced Pluripotent Stem Cell (IPSC) Market?

Key players are concentrating on enhancing their product portfolio through alliances and partnerships with other significant companies and expanding their products through significant R&D. For instance, in January 2021, Bristol Myers Co. awarded USD 6 million to Evotec SE for their collaboration on iPS cell-based neuroscience. This collaboration should aid in the discovery of disease-modifying therapies for a variety of neurogenerative illnesses. Axol Biosciences expanded its service offering in October 2020 by introducing Multi-Electrode Array (MEA) screening for human iPSC-derived cells.

Segmentation of Global Induced Pluripotent Stem Cell (IPSC) Market-

Global Induced Pluripotent Stem Cell (IPSC) Market – By Process

Manual
Automated

Global Induced Pluripotent Stem Cell (IPSC) Market – By Product

Instruments/Devices
Automated Platforms
Consumables & Kits
Services

Global Induced Pluripotent Stem Cell (IPSC) Market – By Workflow

Reprogramming
Cell Culture
Cell Characterization/Analysis
Engineering
Others

Global Induced Pluripotent Stem Cell (IPSC) Market – By Application

Drug Development and Discovery
Regenerative Medicine
Toxicology Studies
Others

Global Induced Pluripotent Stem Cell (IPSC) Market – By End Use

Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & clinics

Global Induced Pluripotent Stem Cell (IPSC) Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Induced Pluripotent Stem Cell (IPSC) Market
2.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Process
2.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Product
2.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Workflow
2.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By Application
2.6. Global Induced Pluripotent Stem Cell (IPSC) Market, By End Use
2.7. Global Induced Pluripotent Stem Cell (IPSC) Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Induced Pluripotent Stem Cell (IPSC) Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Component
3.3.2. Organization Size
3.3.3. Deployment
3.3.4. Platform
3.3.5. End User
3.3.6. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Induced Pluripotent Stem Cell (IPSC) Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Induced Pluripotent Stem Cell (IPSC) Market
7.1. Global Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2021 vs 2028 (in%)
7.1.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Manual, 2016-2028 (US$ Bn)
7.1.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Automated, 2016-2028 (US$ Bn)
7.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2021 vs 2028 (in%)
7.2.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Instruments/Devices, 2016-2028 (US$ Bn)
7.2.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Automated Platforms, 2016-2028 (US$ Bn)
7.2.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By Consumables & Kits, 2016-2028 (US$ Bn)
7.2.6. Global Induced Pluripotent Stem Cell (IPSC) Market, By Services, 2016-2028 (US$ Bn)
7.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2021 vs 2028 (in%)
7.3.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Reprogramming, 2016-2028 (US$ Bn)
7.3.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Cell Culture, 2016-2028 (US$ Bn)
7.3.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By Cell Characterization/Analysis, 2016-2028 (US$ Bn)
7.3.6. Global Induced Pluripotent Stem Cell (IPSC) Market, By Engineering, 2016-2028 (US$ Bn)
7.3.7. Global Induced Pluripotent Stem Cell (IPSC) Market, By Others, 2016-2028 (US$ Bn)
7.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2021 vs 2028 (in%)
7.4.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Drug Development and Discovery, 2016-2028 (US$ Bn)
7.4.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Regenerative Medicine, 2016-2028 (US$ Bn)
7.4.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By Toxicology Studies, 2016-2028 (US$ Bn)
7.4.6. Global Induced Pluripotent Stem Cell (IPSC) Market, By Others, 2016-2028 (US$ Bn)
7.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
7.5.1. Overview
7.5.2. Global Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2021 vs 2028 (in%)
7.5.3. Global Induced Pluripotent Stem Cell (IPSC) Market, By Research & Academic Institutes, 2016-2028 (US$ Bn)
7.5.4. Global Induced Pluripotent Stem Cell (IPSC) Market, By Biotechnology & Pharmaceutical Companies, 2016-2028 (US$ Bn)
7.5.5. Global Induced Pluripotent Stem Cell (IPSC) Market, By Hospitals & clinics, 2016-2028 (US$ Bn)

8. North America Induced Pluripotent Stem Cell (IPSC) Market Analysis
8.1. North America Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
8.5.1. Overview
8.5.2. SRC Analysis
8.6. North America Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
8.6.1. U.S.
8.6.1.1. U.S. Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.6.1.2. U.S. Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
8.6.1.3. U.S. Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
8.6.1.4. U.S. Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
8.6.1.5. U.S. Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
8.6.1.6. U.S. Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
8.6.2. Canada
8.6.2.1. Canada Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.6.2.2. Canada Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
8.6.2.3. Canada Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
8.6.2.4. Canada Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
8.6.2.5. Canada Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
8.6.2.6. Canada Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)

9. Europe Induced Pluripotent Stem Cell (IPSC) Market Analysis
9.1. Europe Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
9.5.1. Overview
9.5.2. SRC Analysis
9.6. Europe Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
9.6.1. Germany
9.6.1.1. Germany Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.1.2. Germany Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.1.3. Germany Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.1.4. Germany Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.1.5. Germany Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.1.6. Germany Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
9.6.2. France
9.6.2.1. France Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.2.2. France Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.2.3. France Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.2.4. France Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.2.5. France Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.2.6. France Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
9.6.3. UK
9.6.3.1. UK Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.3.2. UK Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.3.3. UK Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.3.4. UK Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.3.5. UK Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.3.6. UK Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
9.6.4. Italy
9.6.4.1. Italy Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.4.2. Italy Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.4.3. Italy Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.4.4. Italy Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.4.5. Italy Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.4.6. Italy Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
9.6.5. Spain
9.6.5.1. Spain Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.5.2. Spain Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.5.3. Spain Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.5.4. Spain Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.5.5. Spain Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.5.6. Spain Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.6.6.2. Rest of Europe Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
9.6.6.3. Rest of Europe Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
9.6.6.4. Rest of Europe Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
9.6.6.5. Rest of Europe Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
9.6.6.6. Rest of Europe Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)

10. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market Analysis
10.1. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
10.5.1. Overview
10.5.2. SRC Analysis
10.6. Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
10.6.1. China
10.6.1.1. China Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.1.2. China Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.1.3. China Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.1.4. China Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.1.5. China Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.1.6. China Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
10.6.2. Japan
10.6.2.1. Japan Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.2.2. Japan Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.2.3. Japan Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.2.4. Japan Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.2.5. Japan Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.2.6. Japan Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
10.6.3. India
10.6.3.1. India Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.3.2. India Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.3.3. India Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.3.4. India Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.3.5. India Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.3.6. India Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
10.6.4. South Korea
10.6.4.1. South Korea Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.4.2. South Korea Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.4.3. South Korea Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.4.4. South Korea Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.4.5. South Korea Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.4.6. South Korea Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
10.6.5. South-East Asia
10.6.5.1. South-East Asia Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.5.2. South-East Asia Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.5.3. South-East Asia Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.5.4. South-East Asia Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.5.5. South-East Asia Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.5.6. South-East Asia Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
10.6.6. Rest of Asia Pacific
10.6.6.1. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.6.6.2. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
10.6.6.3. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
10.6.6.4. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
10.6.6.5. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
10.6.6.6. Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)

11. Latin America Induced Pluripotent Stem Cell (IPSC) Market Analysis
11.1. Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
11.5.1. Overview
11.5.2. SRC Analysis
11.6. Latin America Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
11.6.1. Brazil
11.6.1.1. Brazil Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.6.1.2. Brazil Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
11.6.1.3. Brazil Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
11.6.1.4. Brazil Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
11.6.1.5. Brazil Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
11.6.1.6. Brazil Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
11.6.2. Mexico
11.6.2.1. Mexico Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.6.2.2. Mexico Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
11.6.2.3. Mexico Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
11.6.2.4. Mexico Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
11.6.2.5. Mexico Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
11.6.2.6. Mexico Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.6.3.2. Rest of Latin America Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
11.6.3.3. Rest of Latin America Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
11.6.3.4. Rest of Latin America Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
11.6.3.5. Rest of Latin America Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
11.6.3.6. Rest of Latin America Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)

12. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market Analysis
12.1. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028(US$ Bn)
12.5.1. Overview
12.5.2. SRC Analysis
12.6. Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
12.6.1. GCC Countries
12.6.1.1. GCC Countries il Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.6.1.2. GCC Countries Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
12.6.1.3. GCC Countries Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
12.6.1.4. GCC Countries Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
12.6.1.5. GCC Countries Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
12.6.1.6. GCC Countries Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
12.6.2. South Africa
12.6.2.1. South Africa Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.6.2.2. South Africa Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
12.6.2.3. South Africa Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
12.6.2.4. South Africa Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
12.6.2.5. South Africa Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
12.6.2.6. South Africa Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)
12.6.3. Rest of Middle East and Africa
12.6.3.1. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.6.3.2. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC), By Process, 2016-2028 (US$ Bn)
12.6.3.3. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC), By Product, 2016-2028 (US$ Bn)
12.6.3.4. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC), By Workflow, 2016-2028 (US$ Bn)
12.6.3.5. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC), By Application, 2016-2028 (US$ Bn)
12.6.3.6. Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC), By End Use, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Lonza
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Axol Biosciences Ltd.
13.3. Evotec
13.4. Hitachi Ltd
13.5. Merck KGaA
13.6. REPROCELL Inc
13.7. Fate Therapeutics
13.8. Thermo Fisher Scientific Inc
13.9. StemCellFactory III
13.10. Applied StemCell Inc.
13.11. Others

List of Figures

FIG. 1 Global Induced Pluripotent Stem Cell (IPSC) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Induced Pluripotent Stem Cell (IPSC) Market Segmentation
FIG. 4 Global Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2021 (US$ Bn)
FIG. 5 Global Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2021 (US$ Bn)
FIG. 6 Global Induced Pluripotent Stem Cell (IPSC) Market, By Workflow Type, 2021 (US$ Bn)
FIG. 7 Global Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2021 (US$ Bn)
FIG. 8 Global Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2021 (US$ Bn)
FIG. 9 Global Induced Pluripotent Stem Cell (IPSC) Market, by Geography, 2021 (US$ Bn)
FIG. 10 Attractive Investment Proposition, By Process, 2021
FIG. 11 Attractive Investment Proposition, By Product, 2021
FIG. 12 Attractive Investment Proposition, By Workflow Type, 2021
FIG. 13 Attractive Investment Proposition, By Application, 2021
FIG. 14 Attractive Investment Proposition, By End Use, 2021
FIG. 15 Attractive Investment Proposition, by Geography, 2021
FIG. 16 Global Market Share Analysis of Key Induced Pluripotent Stem Cell (IPSC) Market Manufacturers, 2021
FIG. 17 Global Market Positioning of Key Induced Pluripotent Stem Cell (IPSC) Market Manufacturers, 2021
FIG. 18 Global Induced Pluripotent Stem Cell (IPSC) Market Value Contribution, By Process, 2021 & 2028 (Value %)
FIG. 19 Global Induced Pluripotent Stem Cell (IPSC) Market, By Manual, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Induced Pluripotent Stem Cell (IPSC) Market, By Automated, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Induced Pluripotent Stem Cell (IPSC) Market Value Contribution, By Product, 2021 & 2028 (Value %)
FIG. 22 Global Induced Pluripotent Stem Cell (IPSC) Market, By Instruments/Devices, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Induced Pluripotent Stem Cell (IPSC) Market, By Automated Platforms, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Induced Pluripotent Stem Cell (IPSC) Market, By Consumables & Kits, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Induced Pluripotent Stem Cell (IPSC) Market, By Services, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Induced Pluripotent Stem Cell (IPSC) Market Value Contribution, By Workflow, 2021 & 2028 (Value %)
FIG. 27 Global Induced Pluripotent Stem Cell (IPSC) Market, By Reprogramming, Value, 2016-2028 (US$ Bn)
FIG. 28 Global Induced Pluripotent Stem Cell (IPSC) Market, By Cell Culture, Value, 2016-2028 (US$ Bn)
FIG. 29 Global Induced Pluripotent Stem Cell (IPSC) Market, By Cell Characterization/Analysis, Value, 2016-2028 (US$ Bn)
FIG. 30 Global Induced Pluripotent Stem Cell (IPSC) Market, By Engineering, Value, 2016-2028 (US$ Bn)
FIG. 31 Global Induced Pluripotent Stem Cell (IPSC) Market, By Others, Value, 2016-2028 (US$ Bn)
FIG. 32 Global Induced Pluripotent Stem Cell (IPSC) Market Value Contribution, By Application, 2021 & 2028 (Value %)
FIG. 33 Global Induced Pluripotent Stem Cell (IPSC) Market, By Drug Development and Discovery, Value, 2016-2028 (US$ Bn)
FIG. 34 Global Induced Pluripotent Stem Cell (IPSC) Market, By Regenerative Medicine, Value, 2016-2028 (US$ Bn)
FIG. 35 Global Induced Pluripotent Stem Cell (IPSC) Market, By Toxicology Studies, Value, 2016-2028 (US$ Bn)
FIG. 36 Global Induced Pluripotent Stem Cell (IPSC) Market, By Others, Value, 2016-2028 (US$ Bn)
FIG. 37 Global Induced Pluripotent Stem Cell (IPSC) Market Value Contribution, By End Use, 2021 & 2028 (Value %)
FIG. 38 Global Induced Pluripotent Stem Cell (IPSC) Market, By Research & Academic Institutes, Value, 2016-2028 (US$ Bn)
FIG. 39 Global Induced Pluripotent Stem Cell (IPSC) Market, By Biotechnology & Pharmaceutical Companies, Value, 2016-2028 (US$ Bn)
FIG. 40 Global Induced Pluripotent Stem Cell (IPSC) Market, By Hospitals & clinics, Value, 2016-2028 (US$ Bn)
FIG. 41 U.S. Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 42 Canada Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 43 Germany Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 44 France Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 45 U.K. Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 46 Italy Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 47 Spain Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 48 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 49 China Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 50 Japan Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 51 India Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 52 South Korea Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 53 Southeast Asia Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 54 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 55 Latin America Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 56 Brazil Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 57 Mexico Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 58 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 59 Middle East & Africa Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 60 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 61 South Africa Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)
FIG. 62 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Induced Pluripotent Stem Cell (IPSC) Market
TABLE 2 Global Induced Pluripotent Stem Cell (IPSC) Market, by Competitive Benchmarking, 2021
TABLE 3 Global Induced Pluripotent Stem Cell (IPSC) Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Induced Pluripotent Stem Cell (IPSC) Market, by Key Strategies Analysis, 2021
TABLE 5 Global Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 6 Global Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 7 Global Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 8 Global Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 9 Global Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 10 Global Induced Pluripotent Stem Cell (IPSC) Market, by Geography, 2016-2028 (US$ Bn)
TABLE 11 North America Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 12 North America Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 13 North America Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 14 North America Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 15 North America Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 16 North America Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
TABLE 17 US Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 18 US Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 19 US Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 20 US Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 21 US Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 22 Canada Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 23 Canada Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 24 Canada Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 25 Canada Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 26 Canada Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 27 Europe Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 28 Europe Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 29 Europe Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 30 Europe Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 31 Europe Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 32 Europe Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
TABLE 33 Germany Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 34 Germany Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 35 Germany Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 36 Germany Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 37 Germany Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 38 France Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 39 France Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 40 France Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 41 France Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 42 France Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 43 UK Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 44 UK Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 45 UK Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 46 UK Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 47 UK Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 48 Italy Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 49 Italy Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 50 Italy Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 51 Italy Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 52 Italy Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 53 Spain Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 54 Spain Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 55 Spain Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 56 Spain Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 57 Spain Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 58 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 59 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 60 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 61 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 62 Rest of Europe Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 63 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 64 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 65 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 66 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 67 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 68 Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
TABLE 69 China Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 70 China Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 71 China Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 72 China Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 73 China Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 74 Japan Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 75 Japan Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 76 Japan Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 77 Japan Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 78 Japan Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 79 India Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 80 India Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 81 India Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 82 India Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 83 India Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 84 South Korea Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 85 South Korea Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 86 South Korea Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 87 South Korea Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 88 South Korea Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 89 South East Asia Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 90 South East Asia Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 91 South East Asia Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 92 South East Asia Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 93 South East Asia Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 94 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 95 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 96 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 97 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 98 Rest of Asia Pacific Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 99 Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 100 Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 101 Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 102 Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 103 Latin America Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 104 Latin America Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
TABLE 105 Brazil Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 106 Brazil Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 107 Brazil Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 108 Brazil Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 109 Brazil Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 110 Mexico Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 111 Mexico Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 112 Mexico Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 113 Mexico Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 114 Mexico Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 115 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 116 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 117 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 118 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 119 Rest of Latin America Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 120 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 121 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 122 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 123 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 124 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 125 Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, by Country, 2016-2028 (US$ Bn)
TABLE 126 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 127 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 128 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 129 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 130 GCC Countries Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 131 South Africa Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 132 South Africa Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 133 South Africa Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 134 South Africa Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 135 South Africa Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)
TABLE 136 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Process, 2016-2028 (US$ Bn)
TABLE 137 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Product, 2016-2028 (US$ Bn)
TABLE 138 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Workflow, 2016-2028 (US$ Bn)
TABLE 139 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By Application, 2016-2028 (US$ Bn)
TABLE 140 Rest of Middle East and Africa Induced Pluripotent Stem Cell (IPSC) Market, By End Use, 2016-2028 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global induced pluripotent stem cell (IPSC) market?

The rapid introduction of COVID-19 in 2020 caused significant shifts in international healthcare trends and altered how markets operated in these unheard-of circumstances. However, researchers looked at the possibility of using induced pluripotent stem cells to treat coronavirus infections throughout the pandemic.

Which is the leading market for induced pluripotent stem cells (IPSC)?

North America accounted for the highest share in the global induced pluripotent stem cell (IPSC) market.

What are the key drivers for the growth of the induced pluripotent stem cell (IPSC) market?

Increasing cases of chronic diseases and the development of automated IPSC production processes are the major factors driving the market’s growth.

Which is the major segment in the induced pluripotent stem cell (IPSC) market by process type?

Manual production process had a major share in 2021 with around 78% of the market revenue share. Besides, it is also projected to witness the fastest growth.

Which is Workflow’s major segment in the induced pluripotent stem cell (IPSC) market?

The cell culture segment had a major share in the global market in 2021.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –